| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.83B | 23.65B | 23.97B | 24.34B | 26.27B | 31.10B |
| Gross Profit | 12.37B | 13.70B | 13.49B | 14.35B | 15.50B | 18.94B |
| EBITDA | 3.10B | 4.04B | 2.85B | 5.85B | 7.61B | 11.41B |
| Net Income | 749.00M | 1.65B | 1.29B | 1.34B | 5.19B | 6.34B |
Balance Sheet | ||||||
| Total Assets | 50.98B | 54.63B | 52.04B | 53.16B | 46.08B | 46.06B |
| Cash, Cash Equivalents and Short-Term Investments | 28.31B | 33.28B | 30.96B | 34.07B | 25.72B | 30.99B |
| Total Debt | 6.10B | 6.10B | 7.10B | 10.20B | 4.21B | 5.31B |
| Total Liabilities | 10.56B | 13.18B | 11.83B | 14.40B | 7.84B | 10.28B |
| Stockholders Equity | 40.40B | 41.44B | 40.19B | 38.75B | 38.24B | 35.77B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.80B | -246.00M | 5.00B | 4.42B | 9.93B |
| Operating Cash Flow | 0.00 | 3.87B | -84.00M | 5.05B | 4.79B | 10.01B |
| Investing Cash Flow | 0.00 | -1.47B | -73.00M | 1.21B | -3.01B | -4.77B |
| Financing Cash Flow | 0.00 | -2.14B | -3.24B | 4.92B | -4.19B | -3.53B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | ¥34.80B | 10.99 | ― | 0.74% | 22.82% | 811.76% | |
61 Neutral | ¥136.97B | 97.57 | 3.38% | 2.38% | -3.12% | -63.07% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
60 Neutral | ¥41.75B | 9.53 | ― | 4.06% | -15.30% | 39.61% | |
54 Neutral | ¥65.19B | 111.53 | 1.59% | 2.09% | -2.61% | 116.80% | |
52 Neutral | ¥26.98B | -5.14 | ― | ― | -14.71% | -38.87% | |
46 Neutral | ¥17.15B | 9.33 | ― | ― | -37.68% | ― |